Strategy aims to improve collaboration to benefit cancer research
How will collaboration help improve prevention, treatment and patient care?
National Cancer Research Institute (NCRI) has launched its new five year
strategy that aims to strengthen collaboration between funders, researchers and
laid out in the strategy include:
to accelerate the translation of
cancer research into clinical practice
to improve the quality of research
to ensure a co-ordinated portfolio of
cancer research in the UK
from Cancer Research UK show survival rates have doubled over the past 40
years, largely due to outcomes from research.
chair Baroness Delyth Morgan said collaboration will ensure the cancer research
community overcomes the challenges facing them in uncertain political and
NCRI brings together 19 of the country’s biggest charity and government funders
of cancer research.
research is making life-changing advances, but the effects of the disease can
be long lasting with long-term impact on people’s health and quality of life –
meaning the pharmaceutical industry is key in research, development, treatment
and after care
Cancer Research UK: The NCRI partnership launches new five year strategy to accelerate
progress in cancer research